Cargando…
In vivo metabolic effects after acute activation of skeletal muscle G(s) signaling
OBJECTIVE: The goal of this study was to determine the glucometabolic effects of acute activation of G(s) signaling in skeletal muscle (SKM) in vivo and its contribution to whole-body glucose homeostasis. METHODS: To address this question, we studied mice that express a G(s)-coupled designer G prote...
Autores principales: | Meister, Jaroslawna, Bone, Derek B.J., Knudsen, Jonas R., Barella, Luiz F., Liu, Liu, Lee, Regina, Gavrilova, Oksana, Chen, Min, Weinstein, Lee S., Kleinert, Maximilian, Jensen, Thomas E., Wess, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728399/ https://www.ncbi.nlm.nih.gov/pubmed/34883278 http://dx.doi.org/10.1016/j.molmet.2021.101415 |
Ejemplares similares
-
Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells
por: Meister, Jaroslawna, et al.
Publicado: (2022) -
Selective activation of G(s) signaling in adipocytes causes striking metabolic improvements in mice
por: Wang, Lei, et al.
Publicado: (2019) -
β-Arrestin-1 is required for adaptive β-cell mass expansion during obesity
por: Barella, Luiz F., et al.
Publicado: (2021) -
β-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia
por: Pydi, Sai P., et al.
Publicado: (2020) -
Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice
por: Meister, Jaroslawna, et al.
Publicado: (2019)